Exostemtech Venture Capital
<UNKNOWN>, KR · 1 known investors
Exostemtech develops exosome-based therapeutics using platform technologies derived from adult stem cells for treating diseases including osteoarthritis, obesity, diabetes, fatty liver disease, and fibrosis. The company operates in the biotechnology and therapeutic drug development sector.
BiotechDeep TechMedical Devices